labetalol s.a.l.f. 5 mg/ml injektions-/infusionsvätska, lösning
toviaz 4 mg
pfizer pharmaceuticals israel ltd - fesoterodine fumarate - tablets sustained release - fesoterodine fumarate 4 mg - fesoterodine - fesoterodine - treatment of the symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur in patients with overactive bladder syndrome.
toviaz 8 mg
pfizer pharmaceuticals israel ltd - fesoterodine fumarate - tablets sustained release - fesoterodine fumarate 8 mg - fesoterodine - fesoterodine - treatment of the symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur in patients with overactive bladder syndrome.
candesartan heumann 16 mg tabletten
candesartan heumann 32 mg tabletten
candesartan heumann 8 mg tabletten
finomel perifer infusionsvätska, emulsion
nutriflex omega 56/144/40 infusionsvätska, emulsion
equibactin vet. 250 mg/g + 50 mg/g oralt pulver
nutriflex omega 32/64/40 perifer infusionsvätska, emulsion